In the present study, we demonstrated that patients with RA have upregulated percentages of circulating CD4+ T, CD19+ B, Th17, ILC2s, and ILC3s and downregulated percentages of Treg and ILC1s. The gene discussed is CD19; the disease is rheumatoid arthritis.